Management of Drug Development (MS)

A Master of Science degree in the management of drug development will be granted upon completion of at least 32 units of course work. The program is offered on both a full-time and part-time basis, and courses are also available in distance formats.  Course requirements normally include a minimum of three courses concerned with translational aspects of medical product development. Recommended courses to satisfy this core requirement include RSCI 531 , RSCI 532 , PSCI 664  or CXPT 609 . The program must also include a minimum of one course in each of: regulatory science, quality assurance, clinical research, business and statistics. Students should develop a specific plan of study in consultation with graduate advisers before beginning the program.